New platform will enable long-term tracking of cardiomyocytes produced from induced pluripotent stem cells after implantation into the heart
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.